Side effects of azathioprine treatment given for inflammatory bowel disease - A 30 year audit.

被引：5
|
作者：
Fraser, AG [1 ]
Jewell, DP [1 ]
机构：
[1] John Radcliffe Hosp, Dept Gastroenterol, Oxford OX3 9DU, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85289-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4201
引用
收藏
页码：A787 / A787
页数：1
相关论文
共 50 条
  • [21] Audit of cyclosporin use in inflammatory bowel disease: limited benefits, numerous side-effects
    Haslam, N
    Hearing, SD
    Probert, CSJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (06) : 657 - 660
  • [22] Audit of methotrexate treatment for inflammatory bowel disease.
    Fraser, AG
    Jewell, DP
    GASTROENTEROLOGY, 2000, 118 (04) : A1341 - A1341
  • [23] Pellagra, azathioprine and inflammatory bowel disease
    Jarrett, P
    Duffill, M
    Oakley, A
    Smith, A
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1997, 22 (01) : 44 - 45
  • [24] Cyclosporin use in inflammatory arthritis - A two year prospective national audit.
    Lynch, NM
    Robinson, E
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S344 - S344
  • [25] THREE-YEAR STEROID FREE REMISSION AND SAFETY OF AZATHIOPRINE TREATMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Cassieri, C.
    Pica, R.
    Avallone, E. V.
    Corrado, C.
    Zippi, M.
    Vernia, P.
    Paoluzi, P.
    Corazziari, E. S.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E99 - E99
  • [26] OPTIMAL DURATION OF MAINTENANCE TREATMENT WITH AZATHIOPRINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Pica, R.
    Avallone, E. V.
    Cassieri, C.
    Pieroni, A.
    Di Camillo, M.
    De Carolis, A.
    Marinelli, I.
    Vernia, P.
    Paoluzi, P.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S181 - S181
  • [27] Optimal duration of maintenance treatment with azathioprine in patients with inflammatory bowel disease
    Pica, Roberta
    Avallone, Eleonoraveronica
    Cassieri, Claudio
    De Carolis, Aurora
    Zippi, Maddalena
    Vernia, Piero
    Paoluzi, Paolo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 805 - 805
  • [28] Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine
    Alexander, S
    Dowling, D
    INTERNAL MEDICINE JOURNAL, 2005, 35 (09)
  • [29] MTHFR polymorphisms are of pharmacogenetic value in azathioprine treatment in inflammatory bowel disease
    Ansari, A. R.
    Arenas, M.
    Marinaki, A.
    Duley, J.
    Greenfield, S.
    Lewis, C.
    Sanderson, J.
    GUT, 2007, 56 : A105 - A105
  • [30] The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease
    Glas, J
    Török, HP
    Daczo, J
    Tonenchi, L
    Folwaczny, M
    Folwaczny, C
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2005, 10 (12) : 535 - 538
12345